Federated Hermes’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,440
Closed -$84.6K 2184
2023
Q4
$84.6K Buy
+1,440
New +$84.6K ﹤0.01% 1598
2023
Q1
Sell
-25
Closed -$1.13K 2299
2022
Q4
$1.13K Sell
25
-260,245
-100% -$11.8M ﹤0.01% 2050
2022
Q3
$18.2M Sell
260,270
-4,886
-2% -$341K 0.05% 403
2022
Q2
$17.8M Buy
265,156
+5,949
+2% +$399K 0.05% 414
2022
Q1
$21.3M Buy
259,207
+359
+0.1% +$29.5K 0.05% 423
2021
Q4
$38M Buy
258,848
+103,448
+67% +$15.2M 0.07% 331
2021
Q3
$27.5M Buy
155,400
+700
+0.5% +$124K 0.05% 411
2021
Q2
$25M Sell
154,700
-2,139
-1% -$346K 0.05% 432
2021
Q1
$26.9M Sell
156,839
-85,113
-35% -$14.6M 0.05% 421
2020
Q4
$53.1M Buy
241,952
+30,267
+14% +$6.65M 0.11% 236
2020
Q3
$35.2M Buy
211,685
+33,735
+19% +$5.6M 0.08% 280
2020
Q2
$20.3M Buy
177,950
+162,849
+1,078% +$18.6M 0.05% 388
2020
Q1
$1.16M Buy
15,101
+11,782
+355% +$906K ﹤0.01% 1080
2019
Q4
$428K Sell
3,319
-35,245
-91% -$4.55M ﹤0.01% 1479
2019
Q3
$3.01M Sell
38,564
-61,480
-61% -$4.79M 0.01% 906
2019
Q2
$10.3M Sell
100,044
-49,483
-33% -$5.1M 0.03% 575
2019
Q1
$11M Buy
149,527
+71,255
+91% +$5.22M 0.03% 529
2018
Q4
$3.32M Sell
78,272
-42,045
-35% -$1.78M 0.01% 849
2018
Q3
$5.67M Buy
120,317
+86,218
+253% +$4.06M 0.01% 770
2018
Q2
$1.68M Buy
34,099
+29,875
+707% +$1.47M ﹤0.01% 1088
2018
Q1
$130K Sell
4,224
-6,344
-60% -$195K ﹤0.01% 1564
2017
Q4
$193K Sell
10,568
-9,001
-46% -$164K ﹤0.01% 1522
2017
Q3
$229K Sell
19,569
-678
-3% -$7.93K ﹤0.01% 1478
2017
Q2
$74K Buy
20,247
+19,425
+2,363% +$71K ﹤0.01% 1609
2017
Q1
$4K Sell
822
-526
-39% -$2.56K ﹤0.01% 1974
2016
Q4
$6K Buy
+1,348
New +$6K ﹤0.01% 1911
2015
Q2
Sell
-316
Closed -$9K 2091
2015
Q1
$9K Buy
+316
New +$9K ﹤0.01% 1795